Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Pro Shop in the transaction. ro Shop, a new media and commerce company focused on golf, in its...
Pro Shop’s $20 Million Series A Financing Round
Alamar Biosciences’ $128 Million Series C Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Alamar Biosciences in the transaction. Alamar Biosciences announced it raised $128 million in Series C financing round. The financing...
Moonwalk Biosciences’ $57 Million Series A Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Moonwalk Biosciences in the transaction. Moonwalk Biosciences announced it had completed the Series A and Seed financings totaling $57 million....
Star Therapeutics’ $90 Million Series C Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Star Therapeutics in the transaction. Star Therapeutics announced its oversubscribed $90 million Series C financing to continue growth of its...
INTEGRA Biosciences’ Acquisition of Miroculus
Gunderson Dettmer advised Miroculus on the deal. Miroculus announced its acquisition by INTEGRA Biosciences, a medical equipment manufacturer. Miroculus simplifies complicated next generation sequencing (NGS) protocols and...
BillionToOne’s Equity and Debt Financing for Next-Gen Molecular Diagnostics
Gunderson Dettmer represented BillionToOn on the deal. BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to...
Better Stack’s $18.6 Million Series A Financing
Gunderson Dettmer represented Better Stack on the deal. Better Stack, a developer of DevOps tools, announced its $18.6 million Series A financing led by Creandum with...
AstraZeneca’s Acquisition of TeneoTwo
Gunderson Dettmer advised TeneoTwo on the deal. TeneoTwo, a developer of therapeutic antibodies, announced its pending acquisition by AstraZeneca, a bio-pharmaceutical company that focuses on the discovery,...
Ancora Biotech’s $60 Million Series A Financing
Gunderson Dettmer represented Ancora Biotech on the deal. Ancora Biotech, a California-based biotechnology company, announced its $60 million Series A financing co-led by Lightspeed Venture Partners and...
Imply Data’s $100 Million Series D financing
Gunderson Dettmer represented Imply Data on the deal. Imply Data, a California-based developer of a full-stack and multi-cloud platform, announced its $100 million Series D financing led...
Triana’s $110 Million Series A Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Lightspeed Venture Partners on the deal while Mintz represented TRIANA Biomedicines. Lightspeed Venture Partners co-led the $110 million...
Neuron23’s $100 Million Series C Financing
Gunderson Dettmer represented Neuron23 on the deal. Neuron23, a biotechnology company, announced its $100 million Series C financing led by SoftBank Vision Fund 2. Neuron23 focuses on...